Vertex Pharmaceuticals
VRTX
VRTX
611 hedge funds and large institutions have $36.1B invested in Vertex Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 80 funds opening new positions, 270 increasing their positions, 181 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
16% more call options, than puts
Call options by funds: $386M | Put options by funds: $331M
5% more funds holding
Funds holding: 582 → 611 (+29)
0.5% less ownership
Funds ownership: 94.8% → 94.3% (-0.5%)
Holders
611
Holding in Top 10
13
Calls
$386M
Puts
$331M
Top Buyers
| 1 | +$288M | |
| 2 | +$205M | |
| 3 | +$163M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$159M |
| 5 |
Jennison Associates
New York
|
+$146M |
Top Sellers
| 1 | -$586M | |
| 2 | -$395M | |
| 3 | -$292M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$148M |
| 5 |
ClearBridge Investments
New York
|
-$127M |